Universität zu Köln

Hoppe, U. C. and Erdmann, E. (2010). Heart failure update 2010 and current ESC guidelines. Herz, 35 (8). S. 535 - 541. MUNICH: URBAN & VOGEL. ISSN 0340-9937

Full text not available from this repository.

Abstract

Chronic heart failure may be caused by systolic pump failure and/or impairment of diastolic filling of the ventricles. Standard pharmacotherapy of systolic heart failure includes an ACE inhibitor, betablocker, diuretics and in patients with severe symptoms a low-dose aldosterone antagonist. An AT(1) receptor blocker is indicated in those not tolerating ACE inhibitors. If patients remain in functional class NYHA III-IV despite optimal medication and have cardiac dyssynchrony, biventricular pacing may improve symptoms and prognosis. While evidence-based treatment significantly reduces morbidity and mortality in systolic heart failure, hardly any results of clinical trials are available for diastolic heart failure. Therefore, therapy in patients with diastolic heart failure remains symptomatic in most cases.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Hoppe, U. C. UNSPECIFIED UNSPECIFIED UNSPECIFIED Erdmann, E. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-491505
DOI:	10.1007/s00059-010-3396-1
Journal or Publication Title:	Herz
Volume:	35
Number:	8
Page Range:	S. 535 - 541
Date:	2010
Publisher:	URBAN & VOGEL
Place of Publication:	MUNICH
ISSN:	0340-9937
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language CARDIAC-RESYNCHRONIZATION THERAPY; RANDOMIZED CONTROLLED-TRIALS; EJECTION FRACTION; MYOCARDIAL-INFARCTION; PROGNOSTIC IMPORTANCE; EUROPEAN-SOCIETY; TASK-FORCE; MORTALITY; DEFIBRILLATOR; DIAGNOSIS Multiple languages Cardiac & Cardiovascular Systems Multiple languages
URI:	http://kups.ub.uni-koeln.de/id/eprint/49150